000 01333 a2200397 4500
005 20250515070039.0
264 0 _c20071026
008 200710s 0 0 eng d
022 _a0965-2140
024 7 _a10.1111/j.1360-0443.2007.01817.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKruptisky, E M
245 0 0 _aOvercoming opioid blockade from depot naltrexone (Prodetoxon).
_h[electronic resource]
260 _bAddiction (Abingdon, England)
_cJul 2007
300 _a1164-5 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdult
650 0 4 _aDrug Implants
_xtherapeutic use
650 0 4 _aHeroin Dependence
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aInactivation, Metabolic
650 0 4 _aMale
650 0 4 _aNaltrexone
_xpharmacokinetics
650 0 4 _aNarcotic Antagonists
_xpharmacokinetics
650 0 4 _aSecondary Prevention
650 0 4 _aSubstance Withdrawal Syndrome
_xtherapy
700 1 _aBurakov, A M
700 1 _aTsoy, M V
700 1 _aEgorova, V Y
700 1 _aSlavina, T Y
700 1 _aGrinenko, A Y
700 1 _aZvartau, E E
700 1 _aWoody, G E
773 0 _tAddiction (Abingdon, England)
_gvol. 102
_gno. 7
_gp. 1164-5
856 4 0 _uhttps://doi.org/10.1111/j.1360-0443.2007.01817.x
_zAvailable from publisher's website
999 _c17043253
_d17043253